CATALYST BIOSCIENCES

Transcripts Catalyst Biosciences

Equities

CBIO

US14888D2080

Delayed Nasdaq Other stock markets 03:45:10 2024-04-29 pm EDT			5-day change	1st Jan Change
16.37 ^USD	-4.32%		+10.32%	+113.44%

2023	Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index	CI
2023	Beijing Continent Pharmaceutical Co., Ltd. completed the acquisition of Catalyst Biosciences, Inc. in a reverse merger transaction.	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Catalyst Biosciences, Inc., GNI Group Ltd. - Special Call	22-12-27
Transcript : Catalyst Biosciences, Inc., Q3 2021 Earnings Call, Nov 12, 2021	21-11-12
Transcript : Catalyst Biosciences, Inc. - Special Call	21-07-19
Transcript : Catalyst Biosciences, Inc. - Shareholder/Analyst Call	21-06-09
Transcript : Catalyst Biosciences, Inc. - Special Call	20-12-14
Transcript : Catalyst Biosciences, Inc. Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-17-2020 05:00 PM	20-09-17
Transcript : Catalyst Biosciences, Inc. - Special Call	20-02-07
Transcript : Catalyst Biosciences, Inc. - Special Call	19-08-15
Transcript : Catalyst Biosciences, Inc. - Special Call	19-07-08
Transcript : Catalyst Biosciences, Inc. - Special Call	18-12-18
Transcript : Catalyst Biosciences, Inc. - Special Call	18-07-18
Transcript : Catalyst Biosciences, Inc. - Special Call	18-06-18
Transcript : Catalyst Biosciences, Inc., Targacept, Inc. - M&A Call	15-03-06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer